People In The News: Tracking The Latest Industry Personnel Moves
Presidents & CEOs
You may also be interested in...
With its hepatitis C protease inhibitor progressing in Phase III, Medivir starts to transform itself into a profitable specialty pharmaceutical company.
Carole Ben-Maimon presented Barr's Plan B Rx-to-OTC switch application to FDA's Nonprescription Drugs and Reproductive Health Drugs advisory committees.
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.